[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_95":96},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","i6l1fumagcp5p3t047j6jblzm","revision",2,"title","MDxHealth SA 发布 2026 年 10 月 15 日新闻稿","originalTitle","6-K - MDxHealth SA (0001872529) (Filer)","summary","MDxHealth SA 发布 2026 年 10 月 15 日新闻稿。该新闻稿未披露具体业务内容，仅作为文件附件提交。文件未提及任何 AI 模型、产品或技术细节。","reason","source",{"_11":85,"_86":87,"_88":89,"_90":57,"_91":92,"_93":94},"links",{"_82":83,"_63":84},"publishedAt","2026-10-16T10:03:31.000Z","discoveredAt","2026-10-16T11:02:40.061Z","timelineAt","category","tip","tags",[80,81],"stockSymbols",[79],"score",15,"selected",false,"channel","news","story",{"_72":73,"_15":16},"x","readingMode","full","author","language","body",{"_75":-5,"_63":76,"_77":-5,"_78":40},"outline",[],"relatedStories",[74],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","fnNevQhgyuVY",{"_72":73,"_15":16},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","e61142df-b600-46b1-a058-083788d8dcdf",{"_72":73,"_15":16},"zh","

UNITED\nSTATES

SECURITIES\nAND EXCHANGE COMMISSION

Washington,\nD.C. 20549

FORM\n6-K

REPORT\nOF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER\nTHE SECURITIES EXCHANGE ACT OF 1934

For\nthe month of October 2026

Commission\nFile Number 001-40996

MDXHEALTH\nSA

(Translation\nof registrant’s name into English)

CAP\nBusiness Center

Zone\nIndustrielle des Hauts-Sarts

4040\nHerstal, Belgium

+32\n4 257 70 21

(Address\nof principal executive office)

Indicate\nby check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form\n20-F ☒ Form 40-F ☐

MDXHEALTH\nSA

On\nOctober 15, 2026, MDxHealth SA (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit\n99.1.

The\ninformation in the attached Exhibit 99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18\nof the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that\nSection, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended,\nor the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

\n \n \n \n \n \n \n \n \n

Exhibit\n No.		Description\n of Exhibit
99.1		Press Release, dated October 15, 2026

SIGNATURES

Pursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, thereunto duly authorized.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

	MDXHEALTH SA

Date: October 16, 2026	By:	/s/\n Michael McGarrity
		Name:	Michael McGarrity
		Title:	Chief Executive Officer

","zhKind","complete","MDXH","政策与监管","退市","aihot","/items/i6l1fumagcp5p3t047j6jblzm","https://www.sec.gov/Archives/edgar/data/1872529/000121390026109977/0001213900-26-109977-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1792368000&sig=7b6974b5a67903ec","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1792368000&sig=85dc13f192a3fa85 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1792368000&sig=7b2f7276301ea6d9 96w","changelogVersion","2026-10-01T08:00"]